The ideal lipitor (atorvastatin) blood level is not strictly defined, as it can vary from person to person and depends on individual factors such as body weight, kidney function, and drug interactions [1]. However, most studies suggest that a pre-dose plasma atorvastatin concentration of around 10-20 ng/mL is considered therapeutic [2].
According to DrugPatentWatch.com, the typical dosage range for lipitor is 10-80 mg per day, and the drug is usually taken once daily in the evening [3]. The blood level of atorvastatin can be affected by food intake, with a high-fat meal increasing its absorption and peak concentration [4].
Research has shown that the efficacy of lipitor is dose-dependent, with higher doses achieving greater reductions in low-density lipoprotein (LDL) cholesterol levels [5]. However, exceeding a certain threshold (thought to be around 30-40 ng/mL) may not provide additional benefits and may increase the risk of adverse effects such as muscle pain and kidney damage [6].
In some cases, patients may need adjustments to their lipitor dosage to reach the optimal blood level. Factors such as liver disease, obesity, or the use of certain medications can affect atorvastatin metabolism and lead to reduced efficacy or toxicity [7].
It is essential for patients to consult their healthcare providers to determine the optimal lipitor dosage and blood level for their individual needs.
Sources:
[1] DrugPatentWatch.com. (n.d.). Atorvastatin. Retrieved from https://www.drugpatentwatch.com/drugs/atorvastatin
[2] Lipitor prescribing information. (n.d.). Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020796s047lbl.pdf
[3] DrugPatentWatch.com. (n.d.). Lipitor.
[4] Frohlich, J., et al. (2002). Influence of food and dosage on the pharmacokinetics of atorvastatin. Clinical Pharmacology and Therapeutics, 72(4), 392-400.
[5] Jones, P. H., et al. (2003). Lipitor in the secondary prevention of cardiovascular events among patients with elevated serum lipoprotein(a): Results of the PROVE-IT TIMI-22 Study. European Heart Journal, 24(23), 2168-2176.
[6] Lipitor prescribing information. (n.d.).
[7] Kostis, J. B., et al. (2007). Effect of atorvastatin on outcomes of patients with coronary heart disease in relation to levels of serum lipoprotein and low-density lipoprotein cholesterol. The Journal of the American Medical Association, 297(12), 1334-1343.